Tag Archives: shpg

Shire EPS Growth Accelerates, Stock Continues Rebound

Irish drugmaker Shire (SHPG) beat Wall Street’s Q3 estimates and raised its guidance Friday, sending its beleaguered stock up more than 5% on the stock market today to 194.84. Earnings excluding one-time items rose 60% over the year-earlier quarter to $2.93 a share, 46 cents above analysts’ consensus, according to Thomson Reuters. Revenue increased 32% to $1.6 billion, some $140 million more than the Street expected. It was the fifth-straight

Shire Can Thrive Without AbbVie, Say Analysts

Specialty drugmaker Shire faced a future as a stand-alone company Thursday after AbbVie directors late Wednesday voted against a planned acquisition. Investors and analysts seemed optimistic, though, as Shire (SHPG) stock was up 3% in early trading on the stock market today, near 175.50. Leerink analyst Jason Gerberry wrote in a research note Thursday that Shire is unlikely to attract another buyer at this point. Though Pfizer (PFE) and Allergan

Shire Falls, AbbVie Questioned On Buyout Backtrack

Shares of specialty drugmaker Shire plummeted 23% on the stock market today after word got out late Tuesday that big pharma AbbVie is reconsidering its $55 billion buyout of the company. Shire (SHPG) confirmed the reports Wednesday morning with a statement saying that AbbVie ‘s (ABBV) board intends to “consider whether to withdraw or modify its recommendation in light of the impact of the U.S. Treasury Notice” on Sept. 22. The Treasury Notice is